鄰近類別 會議論文/會議摘要 [7/13] 類別統計 近3年內發表的文件:6(14.29%) 含全文筆數:42(100.00%) 文件下載次數統計 下載大於0次:42(100.00%) 下載大於100次:42(100.00%) 檔案下載總次數:18774(81.79%) 最後更新時間: 2024-12-03 09:18 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Lysosomal-targeted doxorubicin deli... How to deal with frenemy NRF2: Targ... Synthesis and structure–activity re... Pilot study: Nutritional and precli... A novel NRF2/ARE inhibitor gossypol... Discovery and development of a nove... Type-3 hyaluronan synthase attenuat... Two new chromones and a new coumari... Xanthine derivatives reveal an allo... c-MYC-directed NRF2 drives malignan...

跳至: (選擇年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目26-42 / 42. (共2頁) << < 1 2  每頁顯示[10|25|50]項目

日期	題名	關聯
2016-08	Desferal regulates hCtr1 and transferrin receptor expression through Sp1 and exhibits synergistic cytotoxicity with platinum drugs in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo	Oncotarget. 2016 Aug;7(31):49310-49321.
2016-07-01	MPT0B098, a microtubule inhibitor, suppresses JAK2/STAT3 signaling pathway through modulation of SOCS3 stability in oral squamous cell carcinoma	PLoS ONE. 2016 Jul 1;11(7):Article number e0158440.
2016-01	2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition	Organic and Biomolecular Chemistry. 2016 Jan;14(2):716-723.
2016-01	Phenyl benzenesulfonylhydrazides exhibit selective Indoleamine 2,3-Dioxygenase inhibition with potent in vivo pharmacodynamic activity and antitumor efficacy	Journal of Medicinal Chemistry. 2016 Jan;59(1):419-430.
2015-12	Novel oxime-bearing coumarin derivatives act as potent Nrf2/ARE activators in vitro and in mouse model	European Journal of Medicinal Chemistry. 2015 Dec;106:60-74.
2015-09	O6-Methylguanine DNA methyltransferase repairs platinum-DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma	International Journal of Cancer. 2015 Sep;137(6):1291-1305.
2015-08	Antimitotic and antivascular activity of heteroaroyl-2-hydroxy-3,4,5-trimethoxybenzenes	Bioorganic and Medicinal Chemistry. 2015 Aug;23(15):4230-4236.
2015-08	Novel Nrf2/ARE activator, trans-coniferylaldehyde, induces a HO-1-mediated defense mechanism through a dual p38alpha/MAPKAPK-2 and PK-N3 signaling pathway	Chemical Research in Toxicology. 2015 Aug ;28(9):1681-1692.
2015-05	Mechanistic basis of a combination D-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo	Biochemical Pharmacology. 2015 May;95(1):28-37.
2015-01	Two new labdane-type diterpene acids from the wood of cunninghamia konishii	Helvetica Chimica Acta. 2015 Jan;98(1):123-127.
2014-05	Azaindolylsulfonamides, with a more selective inhibitory effect on histone deacetylase 6 activity, exhibit antitumor activity in colorectal cancer HCT116 cells	Journal of Medicinal Chemistry. 2014 May;57(10):4009-4022.
2014-04	Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones	European Journal of Medicinal Chemistry. 2014 Apr 22;77(2):306-314.
2013-12	Diterpenoids from the wood of Cunninghamia konishii	Helvetica Chimica Acta. 2013 Dec;96(12):2282-2287.
2013-10	Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure	International Journal of Cardiology. 2013 Oct;168(4):4178-4183.
2013-10	Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: The role of IL-6 signaling and Nrf2/AKR1C axis identification	Biochemical Pharmacology. 2013 Oct;86(7):872-887.
2013-09	Furanylazaindoles: Potent anticancer agents in vitro and in vivo	Journal of Medicinal Chemistry. 2013 Sep;56(20):8008-8018.
2013-06	Heart failure and angiotensin II modulate atrial Pitx2c promotor methylation	Clinical and Experimental Pharmacology and Physiology. 2013 Jun;40(6):379-384.

顯示項目26-42 / 42. (共2頁) << < 1 2  每頁顯示[10|25|50]項目